Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;9(4):505-525.
doi: 10.2217/epi-2016-0096. Epub 2016 Nov 25.

DNA methylation in systemic lupus erythematosus

Christian M Hedrich  1 , Katrin Mäbert  1 , Thomas Rauen  2 , George C Tsokos  3
Affiliations
Review

DNA methylation in systemic lupus erythematosus

Christian M Hedrich et al. Epigenomics. 2017 Apr.

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease facilitated by aberrant immune responses directed against cells and tissues, resulting in inflammation and organ damage. In the majority of patients, genetic predisposition is accompanied by additional factors conferring disease expression. While the exact molecular mechanisms remain elusive, epigenetic alterations in immune cells have been demonstrated to play a key role in disease pathogenesis through the dysregulation of gene expression. Since epigenetic marks are dynamic, allowing cells and tissues to differentiate and adjust, they can be influenced by environmental factors and also be targeted in therapeutic interventions. Here, we summarize reports on DNA methylation patterns in SLE, underlying molecular defects and their effect on immune cell function. We discuss the potential of DNA methylation as biomarker or therapeutic target in SLE.

Keywords: CREM; DNMT; SLE; biomarker; chromatin; epigenetics; inflammation; methylation; transcription factor; treatment.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The work of CM Hedrich is supported by the intramural MeDDrive program, TU Dresden and the Fitz-Thyssen Foundation; GC Tsokos is supported by grants from the National Institutes of Health. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Figures

<b>Figure 1.</b>
Figure 1.. Modifications to cytosine during DNA methylation.
Addition of a methyl group to the 5′ carbon position of cytosine within cytosine-phosphate-guanosine dinucleotides is a highly efficient mechanism for preventing transcription factor recruitment. DNA methylation is mediated through highly conserved enzymes, so-called DNA methyltransferases. DNA hydroxymethylation is the result of oxidation of methylated cytosine-phosphate-guanosine DNA by ten eleven translocation family enzymes, which makes it an intermediate product during active DNA demethylation processes. Hydroxymethylated cytosine may actively be removed by DNA repair pathways, suggesting a role of DNA hydroxymethylation during active DNA demethylation processes.
<b>Figure 2.</b>
Figure 2.. Selected molecular mechanisms contributing to altered DNA methylation in systemic lupus erythematosus.
Cyclic adenosine-monophosphate response element modulator (CREM) α is expressed at increased levels in T cells from systemic lupus erythematosus (SLE) patients. Estrogen receptor signaling, increased CaMK4 activity, CD3/TCR stimulation, increased cellular calcium influx and also reduced DNA methylation of the CREM promoter P1 increase CREM-α expression. CREM-α contributes to regionally increased DNA methylation in SLE T cells through its interactions with DNMT1, and DNMT3a. Conversely, CREM-α reduces DNA methylation of the IL17 gene in a yet to be determined manner. Another DNA demethylation mechanism involves TET proteins in T cells from SLE patients. TET proteins mediate DNA hydroxymethylation (-OH), an intermediate of several active demethylation pathways. Growth arrest and DNA damage-inducible protein alpha (GADD45-α) is overexpressed in SLE T cells and further inducible by UV irradiation. GADD45α in conjunction with activation-induced deaminase, and methyl–cytosine-phosphate-guanosine-binding domain 4 related G:T glycosylase mediates DNA demethylation. Mitogen activated protein kinas (extracellular signal-regulated kinase) activation through the protein kinase C (PKC)-δ can be inhibited by hydralazine, or PP2A (which is increased in T cells from SLE patients). Impaired extracellular signal-regulated kinase activation results in reduced activity of DNMT1. Furthermore, DNMT expression and activity can be altered by miRNAs (miR-126, -129, -143) which are expressed at increased levels in SLE T cells. Examples of affected genes are provided below the depiction of DNA methylation patterns observed in SLE. The above-mentioned molecular mechanisms contributing to altered DNA methylation, however, have not been shown for all genes affected by DNA dysmethylation (also see Tables 1 & 2). AID: Activation-induced deaminase; CREM-α: Cyclic adenosine-monophosphate response element modulator alpha; DNMT: DNA methyltransferase; ERK: Extracellular signal-regulated kinase; MBD4: Methyl-CpG-binding domain 4; TET: Ten eleven translocation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Tsokos GC. Systemic lupus erythematosus. N. Engl. J. Med. 2011;365(22):2110–2121. - PubMed
    1. Crispin JC, Hedrich CM, Tsokos GC. Gene-function studies in systemic lupus erythematosus. Nat. Rev. Rheumatol. 2013;9(8):476–484. - PubMed
    1. Javierre BM, Fernandez AF, Richter J, et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 2010;20(2):170–179. - PMC - PubMed

    2. •• The influence of DNA methylation on systemic lupus erythematosus (SLE) disease expression is demonstrated in genetically identical but disease discordant twins.

    1. Javierre BM, Hernando H, Ballestar E. Environmental triggers and epigenetic deregulation in autoimmune disease. Discov. Med. 2011;12(67):535–545. - PubMed
    1. Hedrich CM. Systemic Lupus Erythematosus. Elsevier; 2016. p. 255.

Publication types

LinkOut - more resources